210 related articles for article (PubMed ID: 27021762)
21. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection.
Bastian I; Coulter C;
Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations.
Mahon J; Beale S; Holmes H; Arber M; Nikolayevskyy V; Alagna R; Manissero D; Dowdy D; Migliori GB; Sotgiu G; Duarte R
BMC Pulm Med; 2022 Oct; 22(1):375. PubMed ID: 36199061
[TBL] [Abstract][Full Text] [Related]
24. Optimizing screening for tuberculosis and hepatitis B prior to starting tumor necrosis factor-α inhibitors in Crohn's disease.
van der Have M; Oldenburg B; Fidder HH; Belderbos TD; Siersema PD; van Oijen MG
Dig Dis Sci; 2014 Mar; 59(3):554-63. PubMed ID: 23949640
[TBL] [Abstract][Full Text] [Related]
25. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
Starke JR;
Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
27. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.
Campbell JR; Sasitharan T; Marra F
Appl Health Econ Health Policy; 2015 Aug; 13(4):325-40. PubMed ID: 26129810
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.
Diel R; Loddenkemper R; Nienhaus A
Chest; 2012 Jul; 142(1):63-75. PubMed ID: 22490872
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
30. [Latent M. tuberculosis infection, update 2011].
Lechartier B; Mazza-Stalder J; Janssens JP; Nicod LP
Rev Med Suisse; 2011 Nov; 7(318):2289-94. PubMed ID: 22400364
[TBL] [Abstract][Full Text] [Related]
31. Interferon-γ release assay for the diagnosis of latent Mycobacterium tuberculosis infection in children younger than 5 years: a meta-analysis.
Ge L; Ma JC; Han M; Li JL; Tian JH
Clin Pediatr (Phila); 2014 Nov; 53(13):1255-63. PubMed ID: 24970465
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
33. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
So H; Yuen CS; Yip RM
Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
[TBL] [Abstract][Full Text] [Related]
34. Sequential strategy for the LTBI screening of newly-arrived immigrants in vulnerable social situations.
Serre-Delcor N; Treviño-Maruri B; Tórtola MT; Fernández-Quevedo M; Soriano-Arandes A; Oliveira-Souto I; Espasa M; Molina I; Ascaso C
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):550-554. PubMed ID: 29223317
[TBL] [Abstract][Full Text] [Related]
35. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
[TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries.
Kowada A
Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cost-effectiveness between the quantiFERON-TB Gold-In-Tube and T-Spot tests for screening health-care workers for latent tuberculosis infection.
Mukai S; Shigemura K; Yamamichi F; Kitagawa K; Takami N; Nomi M; Arakawa S; Fujisawa M
Int J Mycobacteriol; 2017; 6(1):83-86. PubMed ID: 28317810
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
Davidow AL
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy.
Freund R; Granger B; Francois C; Carcelain G; Ravaud P; Mariette X; Fautrel B
Presse Med; 2018 Feb; 47(2):e9-e13. PubMed ID: 29478790
[TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review.
Moon HW; Hur M
Ann Clin Lab Sci; 2013; 43(2):221-9. PubMed ID: 23694799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
